The Premier League’s response to the COVID-19 pandemic

During the COVID-19 pandemic, the Premier League undertook extensive measures to manage its operations amidst unprecedented challenges. Initially, the league swiftly suspended all matches in March 2020 following the outbreak of COVID-19 and subsequent positive cases among players and staff. This decision was made in alignment with government guidelines and public health recommendations.

As the situation evolved, the Premier League embarked on “Project Restart,” a meticulous plan aimed at resuming the season safely. This initiative involved developing rigorous health and safety protocols in collaboration with health authorities and government bodies. Protocols included regular COVID-19 testing for players, coaching staff, and match officials, alongside strict hygiene measures, social distancing guidelines, and the establishment of biosecure bubbles for teams.

The season eventually resumed on June 17, 2020, with matches played behind closed doors and without spectators to minimize the risk of virus transmission. The absence of fans, while essential for public health, presented challenges and required adjustments to maintain the integrity and atmosphere of matches. Efforts were made to enhance the broadcast experience for fans, including innovative camera angles and virtual fan engagement initiatives.

Financially, the Premier League provided significant support to its clubs to mitigate the economic impact of the pandemic. This included advances on merit payments and solidarity payments to ensure clubs remained financially stable during the uncertainty. Additionally, clubs and the league engaged in various community support efforts, such as donating funds to local charities, supporting food banks, and collaborating with the NHS to provide essential resources.

To accommodate the physical demands on players due to the condensed schedule, the Premier League temporarily permitted teams to make up to five substitutions per match instead of the usual three. This measure aimed to reduce the risk of injuries and fatigue among players navigating a congested fixture list.

Throughout the pandemic, the Premier League maintained close communication with stakeholders, including clubs, players, fans, and government authorities. Regular updates were provided on evolving circumstances, health protocols, and the league’s response strategy. Collaborative efforts with health authorities ensured adherence to public health guidelines and facilitated a coordinated approach to managing the crisis.

Recognising the mental health challenges faced by players and staff during this period of uncertainty, the Premier League prioritised mental health support. Resources and services were made available to support the psychological well-being of players and staff, including access to counseling and mental health professionals.

In conclusion, the Premier League’s comprehensive response to the COVID-19 pandemic underscored its commitment to prioritising health and safety while maintaining the continuity of the sport. By implementing stringent health protocols, providing financial support to clubs, and fostering community engagement, the league navigated the challenges posed by the pandemic with resilience and unity.

EQ-5D or MSK-HQ: A commissioning decision

The EQ-5D and the MSK-HQ are both tools used to measure health outcomes, but they serve different purposes and have distinct characteristics. From a commissioner’s perspective in the UK, understanding the key differences between these two instruments is crucial for making informed decisions about healthcare provision and evaluation.

The EQ-5D is a standardised instrument used to measure general health-related quality of life. It is designed to be applicable to a wide range of health conditions and treatments. The EQ-5D includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It also includes a visual analogue scale (VAS) for the patient to rate their overall health.

Advantages of the EQ-5D include its versatility, being applicable to a wide range of diseases and health states, not limited to any specific condition. It allows for comparison across different diseases and treatments, generates utility values that can be used in health economic evaluations including cost-utility analysis, and is widely accepted and used in clinical trials, health surveys, and economic evaluations globally. However, its generic nature might not capture condition-specific details and nuances, and it may be less sensitive to changes in specific conditions such as musculoskeletal disorders compared to condition-specific instruments.

On the other hand, the MSK-HQ is a condition-specific questionnaire designed to measure health outcomes in patients with musculoskeletal (MSK) conditions. It focuses specifically on MSK conditions, including back pain, arthritis, and other musculoskeletal disorders. The MSK-HQ includes 14 items covering pain, physical function, physical activity, sleep, fatigue, emotional well-being, and social participation.

The MSK-HQ’s advantages include its condition-specific focus, which captures the specific issues and outcomes relevant to patients with musculoskeletal conditions. It is more sensitive to changes in health status related to MSK conditions, allowing for more detailed tracking of patient progress and outcomes. Developed with input from patients and clinicians, it ensures coverage of the aspects most important to those with MSK conditions. However, its limited scope makes it unsuitable for use with non-MSK conditions, limiting its applicability in a broader healthcare context. It is less useful for comparing across different types of diseases and treatments outside of MSK conditions, and it does not generate utility values for economic evaluations, limiting its use in cost-utility analyses.

From a commissioner’s perspective, the key differences between the EQ-5D and the MSK-HQ are clear. In terms of applicability, the EQ-5D is suitable for a broad range of health conditions, making it useful for general health assessments and comparisons across different patient groups. The MSK-HQ, however, is specifically designed for musculoskeletal conditions, providing more detailed and relevant information for this patient population. In terms of sensitivity and specificity, the EQ-5D may lack sensitivity for specific conditions, potentially missing important changes in health status in patients with MSK conditions, whereas the MSK-HQ is more sensitive to changes in musculoskeletal health, providing more precise information on patient outcomes in this area.

For economic evaluations, the EQ-5D generates utility values that are essential for cost-utility analysis and economic evaluations in healthcare. In contrast, the MSK-HQ does not provide utility values, limiting its use in economic evaluations. In terms of use cases, the EQ-5D is ideal for broad applications, including public health surveys, clinical trials, and general health assessments. The MSK-HQ is best suited for clinical settings focused on musculoskeletal conditions, rehabilitation programs, and MSK-specific patient monitoring.

Considering patient-centred outcomes, the EQ-5D is more general and may not capture all patient-specific concerns related to musculoskeletal conditions. The MSK-HQ, being developed with direct input from patients and clinicians dealing with MSK conditions, addresses the most relevant aspects of health and quality of life for these patients.

From a commissioner’s perspective, the choice between the EQ-5D and the MSK-HQ depends on the specific needs of the health service being provided. If the goal is to measure health outcomes across a broad range of conditions and perform economic evaluations, the EQ-5D is more appropriate. However, if the focus is on musculoskeletal health, the MSK-HQ provides more detailed and sensitive information that can better inform clinical decisions and patient care strategies.

The EQ-5D and the MSK-HQ are both tools used to measure health outcomes, but they serve different purposes and have distinct characteristics. From a commissioner’s perspective in the UK, understanding the key differences between these two instruments is crucial for making informed decisions about healthcare provision and evaluation.

The EQ-5D is a standardised instrument used to measure general health-related quality of life. It is designed to be applicable to a wide range of health conditions and treatments. The EQ-5D includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It also includes a visual analogue scale (VAS) for the patient to rate their overall health.

Advantages of the EQ-5D include its versatility, being applicable to a wide range of diseases and health states, not limited to any specific condition. It allows for comparison across different diseases and treatments, generates utility values that can be used in health economic evaluations including cost-utility analysis, and is widely accepted and used in clinical trials, health surveys, and economic evaluations globally. However, its generic nature might not capture condition-specific details and nuances, and it may be less sensitive to changes in specific conditions such as musculoskeletal disorders compared to condition-specific instruments.

On the other hand, the MSK-HQ is a condition-specific questionnaire designed to measure health outcomes in patients with musculoskeletal (MSK) conditions. It focuses specifically on MSK conditions, including back pain, arthritis, and other musculoskeletal disorders. The MSK-HQ includes 14 items covering pain, physical function, physical activity, sleep, fatigue, emotional well-being, and social participation.

The MSK-HQ’s advantages include its condition-specific focus, which captures the specific issues and outcomes relevant to patients with musculoskeletal conditions. It is more sensitive to changes in health status related to MSK conditions, allowing for more detailed tracking of patient progress and outcomes. Developed with input from patients and clinicians, it ensures coverage of the aspects most important to those with MSK conditions. However, its limited scope makes it unsuitable for use with non-MSK conditions, limiting its applicability in a broader healthcare context. It is less useful for comparing across different types of diseases and treatments outside of MSK conditions, and it does not generate utility values for economic evaluations, limiting its use in cost-utility analyses.

From a commissioner’s perspective, the key differences between the EQ-5D and the MSK-HQ are clear. In terms of applicability, the EQ-5D is suitable for a broad range of health conditions, making it useful for general health assessments and comparisons across different patient groups. The MSK-HQ, however, is specifically designed for musculoskeletal conditions, providing more detailed and relevant information for this patient population. In terms of sensitivity and specificity, the EQ-5D may lack sensitivity for specific conditions, potentially missing important changes in health status in patients with MSK conditions, whereas the MSK-HQ is more sensitive to changes in musculoskeletal health, providing more precise information on patient outcomes in this area.

For economic evaluations, the EQ-5D generates utility values that are essential for cost-utility analysis and economic evaluations in healthcare. In contrast, the MSK-HQ does not provide utility values, limiting its use in economic evaluations. In terms of use cases, the EQ-5D is ideal for broad applications, including public health surveys, clinical trials, and general health assessments. The MSK-HQ is best suited for clinical settings focused on musculoskeletal conditions, rehabilitation programs, and MSK-specific patient monitoring.

Considering patient-centred outcomes, the EQ-5D is more general and may not capture all patient-specific concerns related to musculoskeletal conditions. The MSK-HQ, being developed with direct input from patients and clinicians dealing with MSK conditions, addresses the most relevant aspects of health and quality of life for these patients.

From a commissioner’s perspective, the choice between the EQ-5D and the MSK-HQ depends on the specific needs of the health service being provided. If the goal is to measure health outcomes across a broad range of conditions and perform economic evaluations, the EQ-5D is more appropriate. However, if the focus is on musculoskeletal health, the MSK-HQ provides more detailed and sensitive information that can better inform clinical decisions and patient care strategies.

The Benefits of Community-Based Musculoskeletal Interface Services in the NHS: A Patient’s Perspective

Living with a musculoskeletal (MSK) condition can significantly impact a patient’s quality of life. MSK conditions, which affect muscles, bones, and joints, are common and can range from acute injuries to chronic syndromes like fibromyalgia. For NHS patients, the integration of community-based MSK interface services has been transformative. Here’s why:

1. Accessibility and Convenience

Community-based MSK services are designed to be closer to home, reducing travel time and providing easier access to care. This is especially beneficial for patients with mobility issues or chronic pain, as it alleviates the stress and fatigue associated with long journeys to hospitals. Additionally, local clinics often offer more flexible appointment times, better accommodating work and personal schedules.

2. Timely Care and Reduced Waiting Times

A significant benefit of community-based services is the reduction in waiting times. Traditional hospital-based MSK services often have long waiting lists, causing delays in diagnosis and treatment. In contrast, community-based services streamline the process with quicker initial assessments and faster referrals to specialists if needed. This timely intervention can prevent conditions from worsening, leading to better outcomes and a quicker return to normal activities.

3. Personalised and Holistic Care

Community-based MSK services tend to adopt a holistic approach to patient care. Practitioners in these settings often have the time to engage more deeply with patients, understanding their personal circumstances and tailoring treatments accordingly. This patient-centered approach ensures that care plans are not only medically appropriate but also practical and achievable for the individual’s lifestyle.

4. Integrated Multi-Disciplinary Teams

Community MSK services are typically staffed by a multi-disciplinary team of healthcare professionals, including physiotherapists, occupational therapists, GPs with a special interest in MSK conditions, and sometimes mental health specialists. This integrated team approach ensures that patients receive comprehensive care that addresses all aspects of their condition. For instance, physiotherapists can provide exercises to improve mobility, while occupational therapists can suggest modifications to everyday activities to reduce pain and strain.

5. Enhanced Patient Education and Self-Management

Empowering patients with knowledge about their conditions and involving them in their treatment plans is a cornerstone of community-based care. These services often provide educational resources and self-management support, teaching patients exercises and strategies to manage symptoms independently. This not only improves patient outcomes but also reduces dependency on healthcare services, fostering a sense of control and confidence in managing one’s health.

6. Stronger Community Connections

Receiving care within the community fosters a sense of belonging and support. Patients often benefit from peer support groups and local resources that offer additional help and encouragement. Knowing that others in the community are going through similar experiences can be incredibly reassuring and motivating, aiding in mental and emotional well-being.

7. Cost-Effectiveness

From a broader perspective, community-based MSK services are cost-effective for the NHS. By reducing the burden on hospital services and preventing the progression of conditions through early intervention, these services help manage healthcare resources more efficiently. This, in turn, ensures the sustainability of the NHS and the continued provision of high-quality care for all.

Conclusion

For patients, the shift to community-based MSK interface services has been overwhelmingly positive. The combination of accessibility, timely care, personalised treatment, integrated support, patient education, and community connection creates a robust framework for effectively managing musculoskeletal conditions. These benefits underscore the importance of continued investment and expansion of community-based MSK services within the NHS, ultimately enhancing patient experiences and outcomes.

Back pain | When is the right time for an MRI scan?

What is an MRI scan?

Magnetic Resonance Imaging (MRI) allows health professionals to look inside a patient’s body.

It is considered a very safe way of producing images that can help diagnose medical conditions.

The scanner uses a high-strength magnet, radio waves and computers to create images that can by your healthcare professional.

What does it show?

  • MRI scans are extremely sensitive and, unlike X-rays which only show bones, MRI scans show bones and soft tissues such as muscles, ligaments and discs.

BUT

  • Research has shown that many of the findings on MRI scans are often found in people without pain.
  • It is normal to have an element of wear and tear or changes to some of the muscles, ligaments or discs as we get older.
  • One study found that up to 90% of healthy people over the age of 60 were reported to have changes to their spinal discs on MRI. It is not an indication that there is something wrong with the spine.
  • While MRI provides excellent pictures of your body structure, it may not be able to pinpoint the specific source of your pain.

When do I need a scan?

MRI for spinal pain should only be used when:

  • A serious condition is suspected. Less than 1% of all back pain is due to serious disease or injury.
  • If symptoms of numbness and weakness in the legs or arms are getting worse despite treatment.
  • If the results of the scan are likely to change your options for treatment.

Thorough examination can determine the best course of management and whether you require a scan.

Is something seriously wrong?

  • Spinal pain is very common, with 80% of people experiencing pain in their backs at least once in their lifetimes.
  • Most new spinal pain will get better on its own within 12 weeks.
  • Less than 1% of all back pain is due to serious disease or injury.
  • Research suggests there is no relationship between the level of pain you feel and the severity of your condition.
  • Health care professionals such as osteopaths, physiotherapists and doctors are specifically trained to identify spinal pain from serious causes.
  • Special questions and a thorough physical examination are very effective for identifying serious causes of back pain.
  • Sometimes blood tests can be a helpful part of the examination process.

Surely I need a scan to tell me what’s wrong with my long standing back pain?

  • The information we get from MRI scans is often unhelpful in treating long standing pain (pain that has persisted for longer than 3 months).
  • Musculoskeletal health care professionals are trained to recognise patterns of pain which indicate when an MRI scan may be useful.
  • Scans tell us nothing about how fit, tight, weak and sensitive our body’s tissues have become. These are often reasons for ongoing pain.
  • Even with modern techniques and knowledge there is often no immediate cure for chronic pain. However, there are many ways to help manage the condition.
  • Your health care professional can discuss techniques, strategies and resources that maybe useful to help manage your problem.

Commonly requested blood tests

Musculoskeletal clinicians often suggest that patients require blood tests in order for a diagnosis to be made, a condition to be excluded or to repeat a test that monitors a particular situation.  Here is some information about the most common types of blood test that are routinely requested.

A Full Blood Count (FBC) is a test that identifies the different types and numbers of cells in your blood. It is a good all-round measure of health. This test can help your doctor decide whether you have anaemia (lack of haemoglobin), whether you have normal white blood cells (which help to fight infection) and normal platelets (cells that clot the blood).

An Erythrocyte Sedimentation Rate (ESR) test screens for inflammation or infection. When you are unwell, whether you have a sore throat, arthritis or almost any other problem, the ESR is raised. The ESR test is often used to monitor whether your treatment is working.

The Anti Nuclear Antibody (ANA) test is ordered to help screen for autoimmune disorders and is most often used as one of the tests to diagnose systemic lupus erythematosus (SLE). Depending on the person’s symptoms and the suspected diagnosis, ANA may be ordered along with one or more other autoantibody tests. Other laboratory tests associated with presence of inflammation, such as erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP), may also be ordered. ANA may be followed by additional tests that are considered subsets of the general ANA test and that are used in conjunction with the person’s clinical history to help rule out a diagnosis of other autoimmune disorders.

An International Normalised Ratio (INR) test will assess whether your blood is clotting normally. It also measures the effect of Warfarin therapy, a drug used to slow down the blood clotting process and help prevent thrombosis.

An Activated Partial Thromboplastin Time (APTT) test is another means of assessing whether your blood is clotting normally.

Elecs (Urea and Electrolytes) is a common test which helps to assess the body’s general condition. It is frequently used to assess whether the kidneys are working properly or to monitor people who take various tablets such as blood pressure medication.

A Liver Function Test (LFT) measures various proteins, enzymes and waste products made or processed by the liver. It helps to determine whether someone may have gall stones, and can identify problems with the liver, such as hepatitis. Some medication can cause liver function tests to become abnormal.

A Glucose test measures how much sugar is in the blood. High levels of glucose in the blood can be a sign of diabetes.

Thyroid Function Tests (TFT [TSH]) look at the activity of the thyroid gland, or levels of thyroid hormone if you are taking supplements. Thyroid hormones control gland production of energy by cells.

A CRP (C-reactive Protein) test measures the concentration in the blood of a protein that indicates inflammation caused by illness, for example during a flare up of rheumatoid arthritis.

A Prot EP (Protein Electrophoresis) test measures different proteins in the blood. Electrophoresis allows us to see proteins such as albumin, which carries substances around the blood and antibodies to infections.

Latex RF is a blood test for rheumatoid factor, a type of antibody present in the blood of some people who have Rheumatoid Arthritis, which causes inflammation of the joints.

A PSA (Prostate Specific Antigen) test is a way of checking the activity of the prostate gland. A high levels of PSA may be a sign of cancer, but it is often raised in other non-cancerous prostate conditions, or if you have an infection. It is not a perfect test for prostate cancer, however, so if your test result is not normal, you will probably need another sort of test, called a biopsy, to be sure whether or not cancer is present.

Amylase is a test that mainly helps to diagnose or monitor diseases of the pancreas. The pancreas helps with digestion and controls blood sugar levels.

Specific things that are tested for in bloods include:
B12 and Folate, which are vitamins needed to make red blood cells. Low levels of Vitamin B12 and folate are associated with a type of anaemia, memory loss and depression.

Ferritin, a protein that stores iron in the body and is important in red blood cell production. Low levels can lead to anaemia.

Cardiac Enzymes (Card Enz), which can be released into the blood by damage to all muscles. As the heart is a muscle, measurement of cardiac enzymes can be used to diagnose a heart attack

Bone Profile, which measures proteins, minerals and enzymes involved in bone turnover. Bone reabsorption is increased by some diseases and these tests can indicate problems with bone.

Cholesterol (Chol), a soft, fatty substance present in all parts of the body. With time, these fats may deposit on the walls of blood vessels so they become narrower, increasing risk of circulatory problems and heart disease. A cholesterol blood test can help determine your risk of developing these.

Urate, a breakdown product of DNA and RNA usually passed out of the body in urine. If the urate level in the blood builds up, it can crystalise and cause inflammation in the joints – a condition called Gout. A urate blood test can help diagnose Gout and monitor the response to treatment.

If you have specific questions about any blood tests that you are having, you should discuss this with the requesting clinician.

 

Safety of Manual Therapy and Manipulation

Introduction
Patients presenting with musculoskeletal symptoms might be offered manual therapy or spinal manipulation as part of a treatment plan or in isolation. The use of manual therapy and spinal manipulation is therefore frequent and the purpose of this essay is to ensure patient safety and the correct use of this specific treatment modality. Whilst manual therapy is considered patient-centred, it remains a passive form of physical therapy where the therapist applies the treatment to the patient.

Broadly, manual therapy is a method of treatment that is commonly used by musculoskeletal physicians, osteopaths, physiotherapists and chiropractors. It aims to quickly reduce pain and improve movement (1) and is clinically and cost-effective (2). Manual therapy treatment can include techniques that glide joints in a rhythmic manner (mobilisation), gap joint surfaces (manipulation) and/or use muscle contractions to restrict or loosen joints. Manual therapy rapidly reduces pain and muscle spasm and allows help with movement. Additionally, manual therapy can help exercise muscles that are not working due to pain – this can help with exercises (3).

Manual therapy is effective in treating neck and back pain and is recommended in national and international treatment guidelines (4). The majority of patients with spinal pain can expect to see a reduction in pain and improvement in function following a course of manual therapy.

The commonest adverse reaction to manual therapy is treatment soreness, which can last a day or two (5, 15). This is a normal, temporary response to having a stiff area of the spine stretched or weak muscles exercised.
Spinal manipulation techniques involve gapping joint surfaces to effectively reduce joint stiffness, muscle spasm and pain (1). There are very rare cases of patients having serious adverse events, including stroke and death, following these techniques (6). These events are associated with damage to the arteries running through the neck. The ‘average’ risk of such events is estimated to be approximately 1 in 2.5 million treatments. (12)

Objectives
This essay is aimed at providing clinical guidelines for the use of manual therapy and spinal manipulation by physicians and clinicians that perform manual therapy and spinal manipulation. The purpose of which is to reduce the risks of adverse reactions and clinical complications.

Definitions
Manual therapy: a general term including hands-on techniques that glide joints in a rhythmic manner (mobilisation), gap joint surfaces (manipulation) and/or use muscle contractions to restrict or loosen joints.

Joint mobilisation: movement up to, but within, normal physiological ranges of joint mobility.

Spinal manipulation: gapping joint surfaces to effectively reduce joint stiffness, muscle spasm and pain.

In practice there is often a ‘grey area’ where joint mobilisation tapers into spinal manipulation. These guidelines are not specifically directed towards spinal manipulation and they should be equally borne in mind for all joint mobilisation techniques. Therefore, these guidelines apply to all forms of manual therapy, and safety depends not just upon good manual technique but also a satisfactory history and musculoskeletal assessment before proceeding to therapeutic procedures of any kind.

It is important to clarify the use of the term “spinal manipulation” in comparison to “joint mobilisation”. Whilst both terms are often used in conjunction when describing manual therapy in general, spinal manipulation’s precise medical usage describes the facilitation of movement beyond normal physiological but within anatomical ranges. This distinction as a therapeutic modality must be clearly documented in clinical records.

Development & evidence base
The evidence base for this guideline has been described in the Introduction. As further evidence emerges for the use of manual therapy and spinal manipulation and the contraindications thereof, clinical guidelines will be updated. Ongoing research into the safety of cervical spine manipulation (13) is likely to impact upon this guideline and it will remain the author’s responsibility to inform the clinical team should any changes in practice need to occur.

Guidance
All patients must have a clinical assessment of their presenting complaint prior to undertaking manual therapy/spinal manipulation, which will include a full case history and physical assessment. Should diagnostic imaging or tests be necessary, all results should be obtained prior to deciding upon the employment of manual therapy or spinal manipulation.

At the first treatment an explanation of the procedure and its possible adverse effects should be given to the patient.

Patients should be asked to give their verbal consent before the first treatment. A record that this information has been imparted and the patient has consented should be recorded in the notes.

Formal written consent is not mandatory (with the exception of persons under 16 in the UK, in which case a parent or carer should be present during the consent process and sign the consent form). This consent form should be signed by the patient and the practitioner and one copy filed in the clinical case notes.

Contraindications to treatment
Whilst spinal manipulation and mobilization remains an extremely safe form of treatment, a number of contraindications to treatment exist and must be adhered to.

Absolute contraindications to treatment
• Where it is more likely that the risks of spinal manipulation will outweigh the potential benefits: –
• Bone disease – tumours, metastases, infection, fractures, bone weakness (long term steroids/osteomalacia, severe osteoporosis), severe inflammatory types of arthritis (not osteoarthritis).
• Neurological considerations – spinal cord compression, moderate to severe nerve root compression from a disc/spondylolisthesis, myeloradiculopathy.
• Rheumatological considerations – active rheumatoid arthritis, ankylosing spondylitis and polymyalgia rheumatica are all contraindications. The last is particularly important as to use manipulation may delay the prescription of steroids and thus risk retinal artery thrombosis and blindness.
• Vascular considerations – the risk of the patient having an aortic aneurysm, severe coagulation deficiencies, severe vertebro-basilar insufficiency (see below), ischemic cervical and thoracic myelopathy must be considered and ruled out where possible. The vascular supply to the spinal cord is only just adequate. A spinal cord already ischaemic should not have manipulative techniques inflicted upon it.
• Lack of clinical hypothesis – where the exact cause of the pain is unclear and there is no obvious mechanism of injury, spinal manipulation should not be used.
• Issues of consent or co-operation – where the patient is unable to clearly understand the aims of treatment, is unable to give their informed consent or where the patient is unable to co-operate with treatment.
• Hypermobility that is severe enough to produce frank instability – lax ligament syndromes/spondylolisthesis. The rheumatoid neck must never be manipulated as life could be at risk by the posterior dislocation of the odontoid process through a weakened or ruptured transverse ligament. Grisels syndrome (1) has been demonstrated radiologically that in children with upper respiratory tract infections there may be hypermobility of the upper cervical spine.

Relative contraindications
• Where it is less clear whether the risks of spinal manipulation will outweigh the potential benefits.
• Adverse reactions to similar treatments in the past.
• Intervertebral disc prolapse – where there has been shown to be a prolapse that is large enough to be causing frank neurological compression.
• Pregnancy – Spinal manipulation and its risks need to be discussed in relation to precipitating a miscarriage (in the first trimester) or premature labour (in the last trimester). The overall risks are low during the second trimester where gentle techniques are advised. (14)
• Osteopenia, osteoporosis, metabolic bone disease
• Hypermobility syndromes with ligamentous laxity. If all movements on pre-manipulative positioning of the patient are painful, manipulation should not be attempted
• Psychological dependence upon manipulative treatment.

Vertebro-Basilar Arterial insufficiency
Episodes of vertebro-basilar arterial insufficiency have been reported to be provoked by manipulation of the cervical spine. The anatomy of the vertebral artery is such that rotation of the upper cervical spine of 30 degrees or more might cause a diminution and even an interruption of the blood flow of the vertebro-basilar artery opposite to the direction of the rotation which may lead to a fatality, although recent evidence suggests the contrary. (16)

The key to the prevention of these problems is in the taking of a careful clinical history. Any symptom such as vertigo, giddiness on turning suddenly or standing up, of loss of consciousness or transient hemiparesis must be carefully elicited and all further neck rotation avoided, (12, 13).

Given a normal history it is reasonable to proceed with the examination having warned the patient to report any giddiness or other relevant symptom and to desist immediately if this happens.

Post treatment management
Risk of minor and moderate adverse events to manual therapy/spinal manipulation is high (circa 50%) but the effects are mild and short lived (15). Patients should be encouraged to contact their clinician should any adverse event last longer than 72 hours. Post treatment, patients may feel sleepy, light-headed, or experience some aching in the areas in which treatment has been directed. Should symptoms progress acutely, medical attention should be sought immediately.

Management of musculoskeletal ‘red flags’
Patients presenting with symptoms suggestive of cauda equina symptoms, muscle weakness or any conditions referred to in 9.1 should not be treated using manual therapy or spinal manipulation and must be managed in a clinically relevant way.

References
1. Herzog W. (2010) The Biomechanics of Spinal Manipulation. Journal of Bodyworks and
Movement Therapies. 14:280-286.

2. Michaleff A.Z., Lin C.-W.C.,Maher C.G., van Tulder M.W. (2012) Spinal Manipulation
Epidemiology: Systematic Review of Cost-Effectiveness Studies. Journal of Electromyography and Kinesiology. 22:655-662.

3. Haavik H., Murphy B. (2012) The role of spinal manipulation in addressing disordered sensorimotor integration and altered motor control. Journal of Electromyography and Kinesiology. 22:768-77.

4. Carragee E.J, van der Velde, et al., Carroll L.J. et al., (2009) Treatment Of Neck Pain: Noninvasive Interventions. Results of the Bone and Joint Decade 2000–2010 Task Force on Neck Pain and Its Associated Disorders. Journal of Manipulative and Physiological Therapeutics. 32:S141-S175.

5. Carnes D., Thomas S, Mars T.S., Mullinger B., Froud R, Underwood M. (2010) Adverse events and manual therapy: A systematic review. Manual Therapy.15: 355–363.

6. Miley M.L., Wellik K.E., Wingerchuk D.M., Demaerschalk B.M. (2008) Does Cervical Manipulative Therapy Cause Vertebral Artery Dissection and Stroke? The Neurologist. 14:1, 66-73.

7. Cassidy J.D., Boyle E., Côté P., He Y., Hogg-Johnson S., Silver F.L., Bondy S.L.(2008) Risk of Vertebrobasilar Stroke and Chiropractic Care. Results of a Population-Based Case-Control and Case-Crossover Study. Spine. 33:4S. S176-S183.

8. Kerry R., Taylor A.J., Mitchell J., McCarthy C., Brew, J. (2008) Manual Therapy and Cervical Arterial Dysfunction, Directions for the Future.

9. Grisel (1930) Enucleation de l’atlas et torticollis nasopharyngien. Presse Med 38,50.

10. Cyriax (1982) Textbook of Orthopaedic Medicine.

11. Ernst and Cantor (2006) A Systematic Review of Spinal Manipulation. JR Soc. Med. 99:279-280

12. Ernst E. (2010) Vascular accidents after neck manipulation: cause or coincidence? Int J Clin Pract;64:673-7

13. Taylor, Alan J. et al. (2010)
A ‘system based’ approach to risk assessment of the cervical spine prior to manual therapy
International Journal of Osteopathic Medicine , Volume 13 , Issue 3 , 85 – 93

14. Stuber, Kent Jason et al (2012)
Adverse events from spinal manipulation in the pregnant and postpartum periods: a critical review of the literature
Chiropr Man Therap. 2012; 20: 8.

15. Carnes, Dawn et al (2009)
Adverse events in manual therapy: a systematic review
National Council for Osteopathic Research

16. Erhardt, Jonathan et al (2015)
The immediate effect of atlanto-axial high velocity thrust techniques on blood flow in the vertebral artery: A randomized controlled trial
Manual Therapy Vol. 20 Iss. 1, February 2015

Infantile Colic

So much has been written about infantile colic recently and there are so many so-called cures available that it must be totally bewildering for parents of newborn babies that are crying persistently or appear distressed.

Such was the confusion when I was seeing patients in an NHS practice, I got together with a referring GP and the team of practice health visitors and discussed the syndrome at length in an attempt to arrive at an accepted definition and, perhaps more importantly, an approach to  how we might offer an acceptable way of meeting demand from struggling parents. The definition is nothing new, and by posting it, we are not claiming that we are right (you might want to have a look at the legal page at this point), but we thought it might just help dispel some of the myths that we are hearing about infantile colic.

This is what we agreed on…

‘Colic’ in infants (under 6 months old) could be described as a collection of simple symptoms, (abdominal discomfort, increased hiccups, difficulty winding, flatulence) which is possibly caused by something as simple as a hypertonic thoracic diaphragm. In the absence of pathology and with medically qualified clinical leadership, simple musculoskeletal, short-term management of the hypertonic diaphragm using inhibition and a suitable feeding/winding/exercise regime might resolve the condition, although for this there is no evidence whatsoever. There is no evidence to suggest that colic is caused by a disruption of any form of neurovascular tissue, subluxation, lesion, or allergy.

This is hardly groundbreaking stuff but it’s been a really useful starting point with parents that are struggling.  I’m posting it here in the hope that it will promote discussion as we are really interested in people’s opinions. It would be very nice to hear from parents that have been through the ‘I have a collicky baby and I’m at the end of my tether’ situation as well as health professionals that either agree, disagree or something politely in between.

We are particularly interested in what evidence there is out there that people are using to base anything other than musculoskeletal treatment on. In coming up with a definition internally, we were meeting a need to explain our own feelings.  By posting it on here, I am not trying to offend those that have other theories – I just think that an enlightening debate is needed and this might help everyone decide what is likely to help or not.

JH